Claire Snyder, PhD, is Professor of Medicine, Division of General Internal Medicine, at the Johns Hopkins School of Medicine with joint appointments in Oncology and Health Policy & Management (Bloomberg School of Public Health). Her research focuses on the quality of cancer care, with emphasis in two areas: quality of life for cancer patients and coordination of care between primary care providers and cancer specialists. She has conducted studies to investigate preventive and comorbid condition care in cancer survivors and has also applied her research to developing survivorship care strategies at Johns Hopkins.
Michael Brundage, MD MSC FRCP(C) is a Professor of Oncology and of Public Health Sciences at Queen’s University at Kingston. He completed his training in Radiation Oncology at the University of Toronto and the Princess Margaret Hospital in Toronto, and in Epidemiology at Queen’s University, where he has enjoyed long-standing affiliations with the Canadian Clinical Trials Group and the Cancer Centre of Southeastern Ontario at Kingston General Hospital.
Dr. Gerard Morton is a radiation oncologist at Sunnybrook Odette Cancer Centre and an Associate Professor at the University of Toronto. He completed medical school and clinical oncology training in Ireland before coming to Toronto as a radiation oncology fellow in the mid 90’s. Over the years, he has developed a clinical and academic focus on GU malignancies and on prostate brachytherapy in particular. He has helped develop one of the leading prostate brachytherapy programs in North America, and through clinical research has helped establish new standard protocols for HDR brachytherapy.